Literature DB >> 21459961

Combination therapy with methotrexate and etanercept for refractory chronic recurrent multifocal osteomyelitis.

Eli M Eisenstein, Grant D Syverson, Sheetal S Vora, Calvin B Williams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21459961     DOI: 10.3899/jrheum.100431

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  6 in total

Review 1.  An Update on the Pathogenesis and Treatment of Chronic Recurrent Multifocal Osteomyelitis in Children.

Authors:  Andrea Taddio; Floriana Zennaro; Serena Pastore; Rolando Cimaz
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

Review 2.  Biologic treatment for chronic recurrent multifocal osteomyelitis: report of four cases and review of the literature.

Authors:  Elena Tronconi; Angela Miniaci; Michelangelo Baldazzi; Laura Greco; Andrea Pession
Journal:  Rheumatol Int       Date:  2017-11-11       Impact factor: 2.631

Review 3.  Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis.

Authors:  Polly J Ferguson; Monica Sandu
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

Review 4.  Chronic recurrent multifocal osteomyelitis.

Authors:  Patrícia Costa-Reis; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2013-05-22       Impact factor: 8.317

Review 5.  Dealing with Chronic Non-Bacterial Osteomyelitis: a practical approach.

Authors:  Andrea Taddio; Giovanna Ferrara; Antonella Insalaco; Manuela Pardeo; Massimo Gregori; Martina Finetti; Serena Pastore; Alberto Tommasini; Alessandro Ventura; Marco Gattorno
Journal:  Pediatr Rheumatol Online J       Date:  2017-12-29       Impact factor: 3.054

6.  Standardized reporting and quantification of whole-body MRI findings in children with chronic non-bacterial osteomyelitis treated with pamidronate.

Authors:  C M Andreasen; R F Klicman; T Herlin; E M Hauge; A G Jurik
Journal:  Pediatr Rheumatol Online J       Date:  2022-10-01       Impact factor: 3.413

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.